China Pharmaceutical Sector Report 2017 2nd Quarter

  • ID: 4420019
  • Report
  • Region: China
  • 60 pages
  • EMIS, A Euromoney Institutional Investor Company
1 of 4
China's Pharmaceutical Sector is Going Through Transformation and Liberalisation, Which are Expected to Narrow the Price Gap Between Local and foreign Drug Manufacturers and to Increase Competition and Sector Consolidation.

FEATURED COMPANIES

  • China Meheco Co Ltd
  • Huadong Medicine Co Ltd
  • MORE
This report provides a complete and detailed analysis of the pharmaceutical sector for China. In-depth business intelligence is presented in a standard format across countries and regions, providing a balanced mix between analysis and data.

What This Report Allows You To Do:
  • Understand the key elements at play in the pharmaceutical sector in China
  • Access forecasts for growth in the sector
  • View key data on production and sales for the sector in China
  • Crystallise the forces both driving and restraining this sector in China
  • Build a complete perspective on sector trade, investment and employment
  • Understand the competitive landscape and who the major players are
  • View M&A activity and major deals
  • Gain an understanding of the regulatory environment for the sector in China
  • Build a clear picture of trends and issues for sub-sectors (western medicine, traditional Chinese medicine).
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • China Meheco Co Ltd
  • Huadong Medicine Co Ltd
  • MORE
1. Executive Summary
Sector in Numbers 2016
Sector Overview
Sector Snapshot
Driving Forces
Restraining Forces

2. Sector In Focus
Quarterly Update
p.12
Quarterly Summary
Sector Outlook
Sector Highlights
Main Sector Indicators
Top M&A Deals
M&A Activity

3. Competitive Landscape
Highlights
Top Pharmaceutical Enterprises
Top Pharmaceutical Manufacturers
Top Pharmaceutical Exporters
Top 10 Listed Companies

4. Companies In Focus
Shanghai Pharmaceuticals Holding Co Ltd
Nanjing Pharmaceutical Co Ltd
Huadong Medicine Co Ltd
China Meheco Co Ltd
Kangmei Pharmaceutical Co Ltd

5. Regulatory Environment
Government Policy
Healthcare Reform 2015
Sector Reform 2015-2016
Anti-Corruption Policies

6. Western Medicine
Highlights
Main Indicators by Segment

7. Traditional Chinese Medicine
Highlights
Main Indicators by Segment
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Shanghai Pharmaceuticals Holding Co Ltd
  • Nanjing Pharmaceutical Co Ltd
  • Huadong Medicine Co Ltd
  • China Meheco Co Ltd
  • Kangmei Pharmaceutical Co Ltd
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll